667 related articles for article (PubMed ID: 18580321)
1. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
2. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
3. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
4. Mammaglobin expression in gynecologic adenocarcinomas.
Hagemann IS; Pfeifer JD; Cao D
Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633
[TBL] [Abstract][Full Text] [Related]
5. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
6. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
7. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
[TBL] [Abstract][Full Text] [Related]
8. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
9. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
10. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
[TBL] [Abstract][Full Text] [Related]
11. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
[TBL] [Abstract][Full Text] [Related]
12. Haymaker gene expression in malignant and normal gynecologic tissues.
Borowsky ME; Das B; Axiotis CA; Malka ES; Abulafia O; Norin AJ
J Histochem Cytochem; 2006 Jul; 54(7):753-61. PubMed ID: 16495475
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma].
Ohwada M; Suzuki M; Tamada T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1237-43. PubMed ID: 2212824
[TBL] [Abstract][Full Text] [Related]
14. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D
Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193
[TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
Mozzetti S; Ferrandina G; Marone M; D'Ingiullo F; Fruscella E; De Pasqua A; Mancuso S; Scambia G
Cancer Detect Prev; 2000; 24(6):536-41. PubMed ID: 11198267
[TBL] [Abstract][Full Text] [Related]
16. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
[TBL] [Abstract][Full Text] [Related]
18. True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Hsu JD; Yao CC; Lee MY; Kok LF; Wang PH; Tyan YS; Han CP
Int J Gynecol Pathol; 2010 May; 29(3):282-9. PubMed ID: 20407331
[TBL] [Abstract][Full Text] [Related]
19. [Expression of annexin I in different histological types of carcinomas].
Xue LY; Teng LH; Zou SM; Ren LQ; Zheng S; Luo W; Bi R; Lü N
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):444-8. PubMed ID: 17974280
[TBL] [Abstract][Full Text] [Related]
20. The value of immunohistochemistry in the differential diagnosis of endometrial carcinomas.
Dallenbach-Hellweg G; Lang-Avérous G; Hahn U
APMIS Suppl; 1991; 23():91-9. PubMed ID: 1715731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
